Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Range Nuclear Renaissance ETF (NUKZ) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Range Nuclear Renaissance ETFTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Range Nuclear Renaissance ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? Range Nuclear Renaissance ETF trades at $58.42 (market cap $662.96M), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.76B). The key difference: Vir Biotechnology Inc. Common Stock is far larger — about 2.7× Range Nuclear Renaissance ETF's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Range Nuclear Renaissance ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Range Nuclear Renaissance ETF for 23 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

NUKZVIR
Market Cap
$662.96M$1.76B
Volume
99,0942,764,948
Sector
Sector/ThematicHealth
52-Week High
$76.23$11.78
52-Week Low
$58.42$5.12
Typical Hold Time
23 Days0 Days
Enterprise Value
—$1.32B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Range Nuclear Renaissance ETF

NUKZ (Range Nuclear Renaissance Index ETF) trades at $60.37, showing minimal daily movement (+0.18%). The technical picture remains bearish with moving averages signaling strong selling pressure, though oscillators suggest neutral momentum. Recent industry developments include Google's 3.6 GW nuclear deal with Constellation Energy and record global nuclear power generation, creating positive sector tailwinds despite the ETF's current technical weakness.

The nuclear energy sector faces both significant catalysts and challenges. Strong demand from AI data centers and federal support for new projects provide growth opportunities, while supply chain bottlenecks and execution risks remain concerns. With the ETF trading near support levels, investors are watching for fundamental improvements to drive price recovery.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NUKZ

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Range Nuclear Renaissance ETF

Range Nuclear Renaissance ETF seeks to track companies related to the nuclear energy industry. Its holdings may include businesses involved in uranium, nuclear power generation, reactors, and nuclear services.

Read more on NUKZ →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →